Paper
3 March 2020 Virtual screened peptides with high affinity to integrin α 5 β 1 for precise tumor identification and treatment
Author Affiliations +
Proceedings Volume 11241, Biophotonics and Immune Responses XV; 112410U (2020) https://doi.org/10.1117/12.2544502
Event: SPIE BiOS, 2020, San Francisco, California, United States
Abstract
Integrin α5β1 is a widely-recognized target for molecular probes in various pathological conditions, especially cancer. The development of computer screening approaches to identify novel high affinity ligands to tumor markers has paved the way for a new generation of tumor identification technology. In this study, we have developed an efficient pharmacophore-based computational strategy to screen two novel peptides, RYr and H5, with high affinity to integrin α5β1. Noninvasive optical imaging data showed that these two peptides could be specifically uptaken by α5β1 overexpressed-tumor cells in vitro and in vivo. And these peptides-based probes could retain in tumor tissue for precise tumor identification. Results indicated that the newly identified peptides with high affinity to integrin α5β1 can be used for precise tumor identification and treatment. And this work exploited more functionalities of pharmacophore-based computational strategy for screening targeting-peptides.
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zhihao Han, Shuaishuai Gong, Zhiyu Qian, and Yueqing Gu "Virtual screened peptides with high affinity to integrin α 5 β 1 for precise tumor identification and treatment", Proc. SPIE 11241, Biophotonics and Immune Responses XV, 112410U (3 March 2020); https://doi.org/10.1117/12.2544502
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Receptors

3D modeling

Tissues

Near infrared

In vitro testing

In vivo imaging

Back to Top